Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Administration reverses course on proposed Medicare drug changes

Administration reverses course on proposed Medicare drug changes

First Edition: March 11, 2014

First Edition: March 11, 2014

Harvard Review of Psychiatry provides updates on ASD research

Harvard Review of Psychiatry provides updates on ASD research

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

Medicare Part D cost-saving plan draws opposition on several fronts

Medicare Part D cost-saving plan draws opposition on several fronts

Further support for hippocampal volume as psychosis biomarker

Further support for hippocampal volume as psychosis biomarker

First Edition: February 27, 2014

First Edition: February 27, 2014

Adults with mental illness more likely to be victims of violence, says study

Adults with mental illness more likely to be victims of violence, says study

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

New drug patent may help overcome problems associated with MDR-TB

New drug patent may help overcome problems associated with MDR-TB

Common mutations produce typical schizophrenia brain changes

Common mutations produce typical schizophrenia brain changes

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Disorganisation, verbal memory help shape QoL in schizophrenia

Disorganisation, verbal memory help shape QoL in schizophrenia

Talking therapy may provide effective alternative to medication for people with schizophrenia

Talking therapy may provide effective alternative to medication for people with schizophrenia

Cognitive therapy promising for patients who shun antipsychotics

Cognitive therapy promising for patients who shun antipsychotics

10-minute neurocognitive measure valid in schizophrenia

10-minute neurocognitive measure valid in schizophrenia

More antipsychotic medications prescribed to children and adolescents in Germany

More antipsychotic medications prescribed to children and adolescents in Germany

Psychiatrists urged to monitor metabolic changes in psychosis patients

Psychiatrists urged to monitor metabolic changes in psychosis patients

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Research reveals new information about the genetic complexity underpinning schizophrenia

Research reveals new information about the genetic complexity underpinning schizophrenia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.